
EMA Updates Flu Vaccination Recommendations
The agency issued its recommendation for the influenza virus strains European vaccine manufacturers should include for 2017.
The European Medicines Agency announced on April 12, 2017 that it had issued an
A decision on a suitable A/Michigan/45/2015 (H1N1)pdm09-like virus strain for live, attenuated vaccines and the specific virus strains recommended are included in the recommendations. Marketing authorization holders should submit applications to change the composition of centrally authorized seasonal flu vaccines by June 12, 2017.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.